This is all the other psychedelic research that came out in April 2020. These papers don’t (yet) have their own page in our database.

Find our recap of the most interesting papers this month in our August Recap.

You can find all interesting papers in our Papers Database.

Related papers

Use CTRL/CMD+F to quickly search if anything relevant for you has been published this month.

• Psychedelic Psychiatry’s Brave New World (commentary by David Nutt, David Erritzoe, Robin Carhart-Harris)
• One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats (very specific research in rats, sponsored by Eleusis – researching anti-inflammatory aspects of psychedelics)
• The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder (literature study, 7 articles, positive comparison of psilocybin versus SSRIs for treatment of major depression)
• Intrinsic Motivations and Perceived Benefits of U.S. Males for Taking Dimethyltryptamine (dissertation, n=13)
• MDMA interactions with pharmaceuticals and drugs of abuse (MDMA has interactions with other drugs, but much is not studied yet)
• Dynamic coupling of whole-brain neuronal and neurotransmitter systems (dMRI, fMRI, and PET study with psilocybin to link anatomy and function of the brain)
• Subacute effects of the psychedelic ayahuasca on the salience and default mode networks (subacute changes in higher-order brain networks)